Brabant pharma Alternatives & Competitors
12 companies similar to Brabant pharma — Pioneering hope for children with Dravet Syndrome through exceptional oral treat...
Companies similar to Brabant pharma
Epygenix Therapeutics, Inc.
We develop precision medicines for rare and refractory epilepsy.
Paramus, United States
Akari Therapeutics, Plc
Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payl...
London, United Kingdom
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Redwood City, United Stat...
X4 Pharmaceuticals
Enabling a better future for people with rare immune disorders
Boston, United States
Track all Brabant pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AGTC
Visionary science for life-changing cures.
Alachua, United States
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Torrance, United States
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
South San Francisco, Unit...
Ultragenyx
Going Beyond Every Day
Novato, United States
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
Illkirch-graffenstaden, F...
CureLauncher
Empowering users to discover personalized medical treatments from Bloomfield Hills, Michig...
Dualyx
Discovery and development of highly innovative biologicals for the treatment of autoimmune...
Belgium
Kynexis
Kynexis is advancing the first potential precision medicine for the treatment of CIAS.
About Brabant pharma
Brabant Pharma is a biotechnology and healthcare startup that focuses on pioneering hope for children with Dravet Syndrome through exceptional oral treatment. Their flagship product, Brabafen, is specifically designed for children suffering from this severe childhood epilepsy, known for causing catastrophic seizures an...
Pharmaceuticals, Pediatric Medicine, Epilepsy Treatment, Orphan Product, Clinical Data, Anticonvulsants, Dravet Syndrome, Rare Diseases, Childhood Epilepsy, Data Exclusivity, Clinical Trials, Cognitive Impairment, Medical Innovation, Licensing, Patient Advocacy
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Brabant pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Brabant pharma on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
